RASSF1 and posterior cortical atrophy: Furthermore, RASSF1A methylation analysis was found to be beneficial as a complementary biomarker to fPSA values in the diagnosis of PCa patients with ambiguous tPSA values between 2–10 ng/mL and GS ≥ 8.